Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	47	49	42	36	35	36
Market Cap Growth	-5.53%	15.82%	16.13%	2.15%	-1.04%	-13.67%
Enterprise Value	41	41	39	37	39	39
Last Close Price	2.63	2.63	2.19	1.81	1.72	1.67
PE Ratio	16.19	9.83	8.23	7.72	13.38	9.42
PS Ratio	1.78	1.72	1.28	1.10	1.37	1.48
PB Ratio	1.00	0.99	0.91	0.74	0.81	0.92
P/TBV Ratio	1.00	1.03	0.94	0.80	0.89	1.04
P/FCF Ratio	26.21	8.72	3.62	13.20	111.66	62.38
P/OCF Ratio	15.94	7.44	3.47	8.42	26.14	21.21
EV/Sales Ratio	1.56	1.47	1.18	1.12	1.50	1.60
EV/EBITDA Ratio	7.82	5.73	5.19	5.20	9.16	7.96
EV/EBIT Ratio	9.92	6.49	6.20	6.48	13.58	10.53
EV/FCF Ratio	22.96	7.44	3.35	13.40	122.00	67.67
Debt / Equity Ratio	0.03	0.04	0.03	0.04	0.06	0.08
Debt / EBITDA Ratio	0.24	0.23	0.20	0.25	0.61	0.60
Debt / FCF Ratio	0.70	0.32	0.13	0.68	8.62	5.35
Asset Turnover	0.45	0.47	0.54	0.56	0.49	0.52
Inventory Turnover	1.83	1.70	1.79	1.61	1.40	1.34
Quick Ratio	2.95	3.14	2.88	2.80	2.49	1.97
Current Ratio	4.19	4.28	3.86	4.25	4.18	3.55
Return on Equity (ROE)	6.30%	10.45%	10.77%	9.55%	6.30%	9.66%
Return on Assets (ROA)	4.38%	6.60%	6.45%	6.06%	3.38%	4.94%
Return on Capital (ROIC)	5.38%	8.09%	7.94%	7.29%	4.03%	5.91%
Return on Capital Employed (ROCE)	8.09%	12.14%	12.58%	10.79%	6.00%	8.72%
Earnings Yield	6.15%	10.17%	12.15%	12.95%	7.47%	10.62%
FCF Yield	3.82%	11.46%	27.64%	7.58%	0.90%	1.60%
Dividend Yield	2.65%	2.70%	4.87%	4.70%	3.29%	4.24%
Payout Ratio	40.58%	36.63%	29.90%	20.25%	44.33%	32.24%
Total Shareholder Return	2.65%	2.70%	4.87%	4.70%	3.29%	4.24%

Source: S&P Capital IQ. Standard template. Financial Sources.